January 05, 2016
The U.S. Food and Drug Administration kicked off 2016 in rousing style this week by suing a Texas drug compounder that challenged the agency's inspection authority, questioning India-based Cadila Healthcare's drug data and chastising medical device makers over myriad missteps.